Study to Evaluate the REMEDY SPECTRUM GV IM Spacer Nail in the Treatment of Ankle-Related Infections
Part of paid clinical trials in Lansing, Michigan.
- Sponsor
- OsteoRemedies, LLC
- Study ID
- NCT06428448
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Periprosthetic Joint Infection
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- REMEDY Spectrum IM Spacer Nail — COMBINATION_PRODUCTThe REMEDY SPECTRUM IM Spacer Nail is a single-use implant made of polymethylmethacrylate (PMMA) which is internally reinforced with a stainless-steel core (ASTM F138, ISO 5832-1). The PMMA of the REMEDY SPECTRUM IM Spacer Nail is laden with gentamicin and vancomycin. The nail has a slot at the distal end and can be combined with the surgeon's choice of fixation to prevent migration depending on the anatomy of the patient. The REMEDY SPECTRUM IM Spacer Nail is available in two lengths (150mm and 300mm) to accommodate variations in patient anatomy. The distal end has a threaded recess for mating with the optional distal cap, as well as the insertion and removal tools.
Study Details
This study is being conducted to evaluate the safety and effectiveness of the REMEDY SPECTRUM IM Spacer Nail in the treatment of ankle-related infections. The study is expected to take approximately 18 months from first subject enrolled to the last follow-up visit. It will have a 12-month enrollment period and a 6-month follow-up. This study is a Prospective, multicenter, single-arm clinical trial. All subjects enrolled in this study will receive the REMEDY SPECTRUM IM Spacer Nail.
Key Dates
- Start date
- Feb 1, 2026
- Status verified
- May 2026
- Primary completion
- Aug 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Subjects with REMEDY Spectrum IM Spacer NailThis is the REMEDY Spectrum IM Spacer Nail treatment group.
Primary Outcome Measure
Successful Treatment of Infection Based on Lab Values and Culture [ Time Frame: 6 months ]
Central Contacts
- Crystal Djaba470-736-7850
- Jacob Schafer
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Michigan Health - Sparrow Clinical Research Institute | Lansing | Michigan | 48190 | Karl Dunn (PRINCIPAL_INVESTIGATOR) |
| OrthoCarolina Research Institute | Charlotte | North Carolina | 28207 | Carroll Jones (PRINCIPAL_INVESTIGATOR) |
| Duke University Medical Center | Durham | North Carolina | 27710 | Karl Murawski (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Lansing, MI
Related Studies
- Treatment of Acute Periprosthetic Joint Infection Comparing Single and Planned Double-Debridement Antibiotics and Implant Retention Followed by Chronic Antibiotic SuppressionEnrolling By Invitation · Mayo Clinic · Jacksonville, Florida
- Optimizing Infection Prophylaxis Prior to Shoulder SurgeryRecruiting · University of Washington · Seattle, Washington